The Thymus Shrinks From Puberty: Ways Scientists Hope to Regrow It
Graded Preliminary — a review that summarizes existing research without new data; it does not show how well the approaches work in people.
Cell, tissue or computational study. Not evidence about people yet, which is why the grade is capped at Preliminary.
- Design
- Narrative review
- Participants
- N/A
- Duration
- —
- Funding
- National Natural Science Foundation of China
The thymus, where immune T cells mature, shrinks from puberty on and then produces fewer and less varied T cells.
Behind the breastbone sits a small organ most adults never think about: the thymus. It is where T cells, key fighters of the immune system, mature. From puberty on, the thymus starts to shrink. It then releases fewer new T cells, and their variety drops. As a result, the immune system copes less well with threats it has never met. The shrinking is also linked to a lasting, low-level inflammation throughout the body.
A review from China sums up how researchers are trying to rebuild the thymus. Approaches include targeting growth hormone, using immune messenger molecules, and drugs that slow mTOR, a growth switch inside cells. Others suppress sex hormones or rely on stem cells, gene therapy and tissue grown in the lab. For each route, the authors describe how it is meant to work, its strengths and its weaknesses.
The authors describe a vicious cycle in which the aging thymus and the aging body drive each other. They see promise in combining several approaches. The review contains no new measurements, though. It cannot tell how well or how safely these methods work in people.
Conflict of Interest Disclosure: The authors report no conflicts of interest.
Disclaimer: Research summaries are provided for informational purposes only and do not constitute medical advice. Always consult a qualified healthcare professional before making changes to your health routine.
